Poliomyelitis: Present epidemiological situation and vaccination problems

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 3, 1998, Pages 278-280

  Mensi, Carolina ^a   Pregliasco, Fabrizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

HUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; VACCINATION;

EID: 0031831895     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.3.278-280.1998     Document Type: Review

References (37)

1. Barbi, M., C. Luraschi, and A. Pozzi. 1991. Soggetti senza documentazione vaccinale pervenuti al settore profilassi del comune di Milano: studio dell'immunità antipoliomielitica. Ig. Mod. 96:480-488.
2. Barbi, M., M. Bardare, C. Luraschi, G. Zehender, M. Clerici Schoeller, and G. Ferraris. 1992. Antibody response to inactivated polio vaccine (eIPV) in children horn to HIV positive mothers. Eur. J. Epidemiol. 8:211-216.
3. Barbuti, S., E. Bellelli, G. M. Fara, and G. Giammanco. 1994. Poliomielite anteriore acuta ed altre sindromi da enterovirus, p. 135-143. In Igiene e Medicina Preventive-1994. Monduzzi Editorc, Bologna, Italy.
4. Beale, A. J. 1990. Polio vaccines: time for a change in immunisation policy? Lancet 335:839-842.
5. Centers for Disease Control and Prevention. 1997. Recommended childhood immunization schedule - United States, 1997. Morbid. Mortal. Weekly Rep. 46:35-40.
6. Centers for Disease Control and Prevention. 1997. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Morbid. Mortal. Weekly Rep. 46(RR3):1-25.
7. Fraizzoli, G., B. M. Sesana, and M. L. Profeta. 1989. Prevalenza degli anticorpi neutralizzanti verso i poliovirus dopo 10 e 15 anni dalla somministrazione del vaccino orale tipo Sabin. J. Prev. Med. Hyg. 30:195-202.
8. Fraizzoli, G., et al. Unpublished data.
9. Goldblum, N., C. B. Gerichter, T. H. Tulchinsky, and J. L. Melnick. 1994. Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area. Bull. W. H. O. 72: 783-796.
10. Green, M. S., J. L. Melnick, D. Cohen, R. Slepon, and Y. L. Danon. 1990. Response to trivalent oral poliovirus vaccine with and without immune serum globulin in young adults in Israel in 1988. J. Infect. Dis. 162:971-974.
11. Kubli, D., R. Stoffen, and M. Schar. 1987. Importation of poliomyclitis to industrialised nations between 1975 and 1984: evaluation and conclusion for vaccination reccomendations. Br. Med. J. 295:169-171.
12. Margalith, M., A. Morgan, and B. Fattal. 1990. Antibodies to polioviruses in an Israeli population and overseas volunteers. J. Med. Virol. 30:68-72.
13. Mc Bean, A. M., and J. F. Modlin. 1987. Rationale for sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States. Pediatr. Infect. Dis. J. 6:881-887.
14. Mensi, C., F. Pregliasco, M. Consonni, and M. G. Galli. 1997. Indagine sieroepidemiologica sull'immunità verso la poliomielite in un campione di popolazione extracomunitaria immigrata in Italia. Riv. Ital. Ig. 57:17-23.
15. Miller, M. A., R. W. Sutter, P. M. Strebel, and S. C. Hadler. 1996. cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA 276:967-971.
16. Ministero della Sanità. 1995. Statistiche relative al secondo semestre 1994. Bol. Epidemiol. 9:268-269.
17. Novello, F., F. Lombardi, C. Amato, et al. 1997. Paralytic poliomyelitis in Italy (1981-85). Eur. J. Epidemiol. 3:54-60.
18. Patriarca, P. A., G. Palmiera, F. Laender, et al. 1988. Randomised trial of alternative formulations of oral poliovaccine in Brazil. Lancet i:429-433.
19. Pezzini, C., M. Limunata, A. Rovelli, C. Uderzo, A. Locasciulli, O. Maglia, G. Masera, M. Barbi, et al. 1994. Immunity to polioviruses and tetanus after bone marrow transplantation in children. Pediatr. Hematol. Oncol. 11:331-336.
20. Pianetti, A., L. Salvaggio, M. R. Biffi, W. Baffone, F. Bruscolini, F. De. Donato, and A. Albano. 1997. Antipoliomyelitis immunity status in a cohort of young men drafted into military service, residing in the suburban Milan area. Eur. J. Epidemiol. 13:725-727.
21. Pregliasco, F., V. Minolfi, B. M. Sesana, A. Andreassi, and M. L. Profeta. 1994. Somministrazione di una dose di vaccino antipoliomielitico tipo Sabin in età adolescenziale: studio della risposta anticorpale e delle escrezioni degli stipiti vaccinali. Riv. Ital. Ig. 4:129-135.
22. Pregliasco, F., G. Grilli, A. Andreassi, E. D'Addezio, F. Vacca, S. Squarcione, L. R. Biasio, and M. L. Profeta. 1996. Immune response to a booster dose of enhanced potency inactivated polio vaccine administered in association with HBV vaccine in adolescents. Vaccine 14:267-269.
23. Pregliasco, F., V. Minolfi, A. Boschin, A. Andreassi, and M. L. Profeta. 1995. A serocpidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts. Eur. J. Epidemiol. 11:693-695.
24. Pregliasco, F., G. Beltramelli, C. Mensi, C. Borghetti, A. Andreassi, A. Tagger, and G. Ziglio. 1995. Ricerca di enterovirus mediante tecniche di biologia molecolare (PCR) in acque destinate al consumo umano, p. 64-71. In Atti della Conferenza Regionale Acqua Potabilc e Salute 2, Desenzano (Brescia-Italy), 1995.
25. Profeta, M. L. 1989. Poliomielite: on problema ancora attuale. Vaccinazione 2000 3:4-6.
26. Reali, D., A. Carducci, and M. A. Ruschi. 1990. Serum antibodies in a Tuscan population, Italy. Eur. J. Epidemiol. 6:309-312.
27. Santoro, R., F. Lumbardi, F. Novello, et al. 1984. Serum antibodies to poliomyelitis in Italy. Bull. W. H. O. 62:591-595.
28. Sutter, R. W., P. A. Patriarca, S. Brogan, et al. 1991. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 338:715-720.
29. World Health Organization. 1996. Progress towards the global eradication of poliomyelitis, 1995. Weekly Epidem. Rec. 71:189-194.
30. World Health Organization. 1994. Certification of poliomyelitis eradication - the Americas, 1994. Weekly Epidem. Rec. 69:293-295.
31. World Health Organization. 1992. Poliomyelitis outbreak: Bulgaria. Weekly Epidem. Rec. 67:336-337.
32. World Health Organization. 1992. Poliomyelitis outbreak: Netherlands. Weekly Epidem. Rec. 67:341-344.
33. World Health Organization. 1993. Mass vaccination campaigns to control the 1991-1992 poliomyelitis outbreak: Jordan. Weekly Epidem. Rec. 68: 222-223.
34. World Health Organization. 1993. Poliomyelitis outbreak, 1992: Malaysia. Weekly Epidem. Rec. 68:297-300.
35. World Health Organization. 1988. Poliomyelitis outbreak in Israel. Weekly Epidem. Rec. 63:325-326.
36. World Health Organization. 1996. Poliomyelitis outbreak: Albania. Weekly Epidem. Rec. 71:293-295.
37. World Health Organization. 1990. Change in the poliomyelitis immunisation programme. Weekly Lpidem. Rec. 65:251-252.